Dashboard
Manage Tickers

ICPTINTERCEPT PHARMACEUTICALS, ...

Nasdaq interceptpharma.com


$ 19.01 $ 0.04 (0.21 %)    

Tuesday, 07-Nov-2023 15:59:56 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 19
$ 18.98
$ 0.00 x 0
$ 0.00 x 0
$ 18.98 - $ 19.01
$ 8.82 - $ 21.86
3,963,455
na
794.05M
$ 1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2023 09-30-2023 10-Q
2 08-02-2023 06-30-2023 10-Q
3 04-27-2023 03-31-2023 10-Q
4 03-02-2023 12-31-2022 10-K
5 11-01-2022 09-30-2022 10-Q
6 08-03-2022 06-30-2022 10-Q
7 05-06-2022 03-31-2022 10-Q
8 03-02-2022 12-31-2021 10-K
9 11-03-2021 09-30-2021 10-Q
10 07-29-2021 06-30-2021 10-Q
11 05-06-2021 03-31-2021 10-Q
12 02-25-2021 12-31-2020 10-K
13 11-09-2020 09-30-2020 10-Q
14 08-10-2020 06-30-2020 10-Q
15 05-11-2020 03-31-2020 10-Q
16 02-25-2020 12-31-2019 10-K
17 11-05-2019 09-30-2019 10-Q
18 08-08-2019 06-30-2019 10-Q
19 05-08-2019 03-31-2019 10-Q
20 03-01-2019 12-31-2018 10-K
21 11-01-2018 09-30-2018 10-Q
22 08-07-2018 06-30-2018 10-Q
23 05-10-2018 03-31-2018 10-Q
24 02-28-2018 12-31-2017 10-K
25 11-06-2017 09-30-2017 10-Q
26 08-03-2017 06-30-2017 10-Q
27 05-10-2017 03-31-2017 10-Q
28 03-01-2017 12-31-2016 10-K
29 11-09-2016 09-30-2016 10-Q
30 08-09-2016 06-30-2016 10-Q
31 05-10-2016 03-31-2016 10-Q
32 02-29-2016 12-31-2015 10-K
33 11-09-2015 09-30-2015 10-Q
34 08-07-2015 06-30-2015 10-Q
35 05-11-2015 03-31-2015 10-Q
36 03-02-2015 12-31-2014 10-K
37 11-06-2014 09-30-2014 10-Q
38 08-11-2014 06-30-2014 10-Q
39 05-09-2014 03-31-2014 10-Q
40 03-14-2014 12-31-2013 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cymabay-therapeutics-deal-may-not-be-needle-moving-for-100b-valued-gilead-but-acquisition-is-reasonably-priced-analyst
CymaBay Therapeutics Deal May Not Be Needl...
02/13/2024 19:05:04

Gilead's acquisition of CymaBay Therapeutics for $4.3 billion strengthens its liver disease portfolio. Analysts see potenti...

intercept-announces-new-phase-2-data-showing-significant-impact-of-oca-bezafibrate-combination-on-normalization-of-multiple-key-biomarkers-of-pbc-induced-liver-damage-at-aasld-the-liver-meeting-2023
Intercept Announces New Phase 2 Data Showi...
11/13/2023 13:33:18

Data from two Phase 2 studies in PBC show combination of OCA + bezafibrate achieved biochemical remission (normalization of ALP...

intercept-announces-new-findings-from-long-term-extension-of-landmark-poise-trial-in-pbc-showing-importance-of-biomarkers-beyond-alp-at-aasld-the-liver-meeting-2023
Intercept Announces New Findings From Long...
11/10/2023 13:02:33

New analysis demonstrates the impact of OCA on achievement of GGT <3.2×ULN and ALP <1.5×ULNFindings suggest that OCA has ...

alfasigma-spa-announces-expiration-of-hart-scott-rodino-waiting-period-in-connection-with-pending-acquisition-of-intercept-pharmaceuticals-inc
Alfasigma S.p.A. Announces Expiration Of H...
10/26/2023 13:09:52

Alfasigma S.p.A. ("Alfasigma") today announced that the required waiting period under the Hart-Scott-Rodino Antitrust I...

top-5-health-care-stocks-that-should-keep-you-up-at-night
Top 5 Health Care Stocks That Should Keep ...
10/26/2023 12:49:06

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

emas-human-medicines-committee-has-started-a-review-of-the-medicine-ocaliva-study-747-302-failed-to-show-that-ocaliva-was-more-effective-than-placebo-additionally-side-effects-including-serious-ones-occurred-more-frequently-in-patients-treated-with-ocaliva
EMA's Human Medicines Committee Has Starte...
10/13/2023 19:57:23

https://www.ema.europa.eu/en/documents/referral/ocaliva-article-20-procedure-review-ocaliva-started_en.pdf  

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
10/02/2023 17:35:22

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
09/28/2023 17:35:26

b-riley-securities-downgrades-intercept-pharma-to-neutral-raises-price-target-to-19
B. Riley Securities Downgrades Intercept P...
09/27/2023 16:18:42

B. Riley Securities analyst Mayank Mamtani downgrades Intercept Pharma (NASDAQ:ICPT) from Buy to Neutral and raises the pric...

rbc-capital-maintains-sector-perform-on-intercept-pharma-raises-price-target-to-19
RBC Capital Maintains Sector Perform on In...
09/27/2023 15:25:26

RBC Capital analyst Brian Abrahams maintains Intercept Pharma (NASDAQ:ICPT) with a Sector Perform and raises the price targe...

benzingas-top-ratings-upgrades-downgrades-for-september-27-2023
Benzinga's Top Ratings Upgrades, Downgrade...
09/27/2023 15:00:45

analyst-expectations-for-intercept-pharmas-future
Analyst Expectations for Intercept Pharma'...
09/27/2023 13:01:09

hc-wainwright--co-downgrades-intercept-pharma-to-neutral-announces-19-price-target
HC Wainwright & Co. Downgrades Intercept P...
09/27/2023 10:44:49

HC Wainwright & Co. analyst Ed Arce downgrades Intercept Pharma (NASDAQ:ICPT) from Buy to Neutral and announces $19 pric...

canaccord-genuity-downgrades-intercept-pharma-to-hold-lowers-price-target-to-19
Canaccord Genuity Downgrades Intercept Pha...
09/27/2023 08:45:14

Canaccord Genuity analyst Edward Nash downgrades Intercept Pharma (NASDAQ:ICPT) from Buy to Hold and lowers the price target...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
09/26/2023 17:31:02

why-td-synnex-shares-are-trading-lower-by-over-5-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why TD SYNNEX Shares Are Trading Lower By ...
09/26/2023 16:56:35

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results...

fisker-intercept-pharmaceuticals-immunovant-and-other-big-stocks-moving-higher-on-tuesday
Fisker, Intercept Pharmaceuticals, Immunov...
09/26/2023 14:49:13

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in ...

dow-tumbles-150-points-us-house-prices-rise-in-july
Dow Tumbles 150 Points; US House Prices Ri...
09/26/2023 13:46:02

U.S. stocks traded lower this morning, with the Dow Jones falling around 150 points on Tuesday. Following the market opening T...

why-is-rare-liver-disease-focused-intercept-pharmaceuticals-stock-trading-higher-today
Why Is Rare Liver Disease Focused Intercep...
09/26/2023 13:30:10

Italy-based Alfasigma has agreed to acquire Intercept Pharmaceuticals Inc (NASDAQ: ICPT) for 

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
09/26/2023 13:06:07

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION